Industry Partner News: Santhera's SIDEROS trial currently enrolling

The SIDEROS clinical trial, sponsored by Santhera, is currently recruiting boys with DMD ages 10 and older at 24 trial sites in the U.S. The study will compare the efficacy of idebenone to placebo in boys and men currently on steroids. Idebenone is an investigational drug in Phase 3 development for patients with DMD who are in respiratory decline. For more information on the study and enrollment eligibility, please view their newsletter update or visit www.siderosdmd.com.